Barclays maintains MGIC Investment at Equal-Weight, raises price target to $30 from $29
Barclays kept MGIC Investment's rating at Equal-Weight but increased its price target to $30 from $29, a 3.4% rise. This implies a 2.2% upside from the Nov 5 close of $29.35, according to the bank.
How this was made

The 30-second read
Why it matters
The target increase may prompt short-term buying but is unlikely to drive a significant price move.
Market read
A small analyst upgrade with limited trading impact.
What to watch
No new fundamental data released; the change is purely analyst opinion.
Background
Barclays maintains an equal-weight rating on MGIC Investment and adjusts its price target.
Market effects
Minor impact on mortgage insurance sector, limited to MGIC.
U.S. market only, no broader regional effect.
Low global relevance.
Counterpoint
Target raise is modest; price may already reflect the outlook, limiting upside.
Key entities
- AnalystBarclays
Equity research firm providing the rating and target.
- CompanyMGIC Investment Corp.
Mortgage insurance provider whose stock is affected.



